Magnetic Resonance Imaging (MRI) guided audiovisual biofeedback for precise lung cancer radiotherapy

This study is an imaging study which aims to evaluate whether the use of magnetic resonance imaging (MRI) guided audiovisual biofeedback system can improve the precision of lung cancer radiotherapy. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with stage I-III lung cancer for which you will be treated with radical radiotherapy with or without chemotherapy. Study details All participants will attend 3 additional sessions to standard care. The first session is a breathing training session with audiovisual feedback. This will involve a visual display of a respiratory waveguide. Participants will be asked to regulate their breathing to keep a red ball within the blue wave guide. The aim is for the ball to stay within the line by adjusting breathing by the participant. The second and third sessions participants will undergo MRI scans with and without audiovisual feedback. These MRI sessions will occur pre-radiotherapy treatment and mid-treatment (3 to 6 weeks later). All imaging protocols used are approved clinical procedures. The acquired images will be used to evaluate the reproducibility of respiratory-related tumour motion and whether this leads to improved treatment precision i.e. a reduction in radiotherapy dose delivered to healthy tissues.